Breaking News, Promotions & Moves

Scorpius BioManufacturing Names Gary Welch as Interim President

Welch will lead the company through its next phase of growth with a focus on mammalian & microbial biologics and new modalities.

Scorpius BioManufacturing, a Texas-based biologics contract research and contract development & manufacturing organization (CDMO), has appointed Gary Welech interim president.   With a career spanning more than 30 years in biopharmaceuticals at large manufacturers like AbbVie and biotech innovators like Agensys and CytomX, Welch will lead Scorpius through its next phase of growth, focused on serving clients working on mammalian & microbial biologics and new modalities. Jeff Wol...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters